Sun Pharma’s Mega Deal Creates Buzz !

Sun Pharmaceutical Industries has announced that it will acquire US-based healthcare company Organon & Co. in a massive deal valued at 11.75 billion dollars. The company stated that the acquisition will be completed entirely through cash payments at 14 dollars per share.

With this acquisition, Sun Pharma is expected to strengthen its global presence significantly. Reports suggest that the company could enter the list of the world’s top 25 pharmaceutical companies after the completion of the deal.